UCLA Health has made extraordinary advancements in the field of theranostics within a short span, particularly noted through the establishment of its Outpatient Theranostics Center in Westwood. Since opening in February 2024, this facility has dedicated itself to the treatment of advanced prostate,
The advancements in nuclear imaging techniques and the introduction of treatments to decelerate Alzheimer's progression have spurred significant updates to the appropriate use criteria (AUC) for amyloid and tau PET imaging. These updates, the first in over a decade, reflect collaborative efforts by
In light of the growing national shortage of medical imaging technologists in the United States, there is an urgent need for innovative educational programs and strategic partnerships to address this critical issue. A shining example of this effort is the journey of Aisseta Sall, also known as
Fevers of unknown origin (FUO) present a daunting challenge for clinicians, as they account for approximately 2% of hospitalizations and require extensive diagnostic efforts to identify their often elusive causes. The publication of new imaging criteria, developed collaboratively by the Society of
Nuclear medicine represents a transformative advancement in medical diagnostics, crucial for its ability to not only show the structure of our inner workings but also to reveal the function of our organs and tissues with great specificity. The practice harnesses the power of radiopharmaceuticals –
In recent years, radiopharmaceuticals have emerged as a groundbreaking development in the field of cancer therapy. These sophisticated compounds, designed to target and destroy cancer cells with minimal damage to surrounding healthy tissue, are revolutionizing cancer treatment. This comprehensive
